BAC
Bank of America Corporation
BAC has the edge over RWAY overall, supported by stronger valuation and stronger fundamentals.
RWAY
Runway Growth Finance Corp.
RWAY trails on the overall score without a compensating advantage in the available component scores.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
RWAY Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Healthy | |
| N/A | |
| N/A |
RWAY's profitability is currently healthy, but its revenue is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like RWAY.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over RWAY in the historical PE scenario, which offers more potential upside but is not a forecast.
RWAY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.9x | $6.66 | — |
| Cheap | 6.4x | $1.02 | -85% |
| Fair | 11x | $1.76 | -74% |
| Expensive | 15x | $2.45 | -63% |
| Current | 42x | $6.66 | — |
Historical ranges are pointers, not guarantees.
RWAY's PE is in its expensive range at 42x. If earnings grow as analysts expect, today's price would be 4.9x next year's earnings, in its cheap range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over RWAY on the outlook, with more favorable profitability expectations.
RWAY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for RWAY, but weaker profitability.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over RWAY on earnings, with more consistent year-over-year improvement.
RWAY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.35 | +745% |
| Q3 2026 | $0.16 | -89% |
| Q2 2026 | $0.12 | -94% |
| Q1 2026 | -$0.08 | -105% |
| Q4 2025 | $0.93 | -51% |
| Q3 2025 | $1.45 | +41% |
| Q2 2025 | $1.88 | +151% |
| Q1 2025 | $1.64 | +50% |
| Q4 2024 | $1.89 | +73% |
RWAY's earnings per share have fallen from their peak: $0.16 over the past year, against $1.89 in late 2024.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the stronger quarterly revenue trend. Revenue is up 6.7% for BAC versus down 64% for RWAY.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
RWAY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2022 | $3.2M | -64% |
| Q1 2022 | $5.7M | -49% |
| Q4 2021 | $20.9M | -6.4% |
| Q3 2021 | $13.1M | +7.2% |
| Q2 2021 | $9M | -39% |
| Q1 2021 | $11.3M | +267% |
RWAY's revenue has slid since its 2020 peak: $3M last quarter, down 64% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2022 | -25% | -100 points |
| Q1 2022 | 50% | -33 points |
| Q4 2021 | 92% | -0.6 points |
| Q3 2021 | 78% | -11 points |
| Q2 2021 | 75% | -17 points |
| Q1 2021 | 83% | N/A |
| Q4 2020 | 93% | +36 points |
| Q3 2020 | 89% | N/A |
RWAY's operating margin was −25% last quarter, down 100 points from the same quarter a year ago, near the bottom of its range since 2020.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over RWAY on cash generation, producing positive trailing cash flow while its opponent burns cash.
RWAY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $150.2M | +63% |
| Q2 2026 | -$194.3M | -$194.1M |
| Q1 2026 | $5.9M | -92% |
| Q4 2025 | $20.6M | +49% |
| Q3 2025 | $92.4M | +257% |
| Q2 2025 | -$297K | +$38.3M |
| Q1 2025 | $73.6M | +7.2% |
| Q4 2024 | $13.9M | +$75.5M |
RWAY's free cash flow was −$18M over the past year, against $180M the year before. Free cash flow isn't a meaningful measure for financial services companies like RWAY.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over RWAY on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
RWAY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -188K shares |
| 1 year | +16% | +5.7M shares |
| 3 years | +3.4% | +1.4M shares |
| 5 years | +26% | +8.7M shares |
| Available history | +1.2% | +506K shares |
RWAY has 42M diluted shares, up 16% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.8M |
| Q4 2025 | — |
| Q3 2025 | $4.4M |
| Q4 2024 | $5.8M |
| Q3 2024 | $6.7M |
| Q2 2024 | $12.8M |
| Q1 2024 | $10.6M |
| Q4 2022 | $1.5M |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
RWAY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2022 | 5.4x | High |
| Q1 2022 | 3.1x | Elevated |
| Q4 2021 | 1.5x | Healthy |
| Q3 2021 | 1.7x | Healthy |
| Q2 2021 | 2.4x | Moderate |
| Q1 2021 | 2.5x | Moderate |
RWAY's net debt is about 5.4 years of its operating earnings (EBITDA), up from 2.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like RWAY.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
RWAY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.9 | Neutral |
| Stochastic | 72.1 | Neutral |
RWAY's weekly RSI is 51 (neutral) and its Stochastic is 72 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over RWAY on valuation relative to its sector.
RWAY PE vs Financial Services Sector
| Metric | RWAY | Sector median | Relative |
|---|---|---|---|
| PE | 42x | 13x | 220% above |
| PE % | 94 | 64 | 30 pts above |
RWAY is trading at 42x earnings, a 220% premium to the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
RWAY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.55 | 1.7% above |
| 20 week MA | $6.33 | 5.2% above |
| 50 week MA | $7.06 | 5.7% below |
| 100 week MA | $8.74 | 24% below |
| 200 week MA | $10.4 | 36% below |
RWAY has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over RWAY on returns for 2026, with the stronger performance.
RWAY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $12.5 | $13.4 | +7.3% |
| 2022 | $13.4 | $12.2 | -9.4% |
| 2023 | $12.2 | $12.6 | +3.6% |
| 2024 | $12.6 | $10.9 | -13% |
| 2025 | $10.9 | $8.93 | -18% |
| 2026 YTD | $8.93 | $6.66 | -25% |
RWAY has finished lower in three of the last five years. It's down 25% so far in 2026.